SARS-CoV 2: Clinical Trials

1 trial for SARS-CoV 2, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow SARS-CoV 2: new trials by email Literature Review of SARS-CoV 2 trials Research Report on SARS-CoV 2

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement
BCG, Placebo - COVID-19, Therapeutic Vaccine
Phase 4CompletedUniversity of Campinas, Brazil4002020-10-012023-11-30

Narrower conditions

COVID-19 (1)

Broader conditions

Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Nidovirales Infections (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)  ·  Virus Diseases (1)

Interventions

BCG Vaccine (1)

Sponsors

University of Campinas, Brazil (1)

Countries

Brazil (1)

Top investigators

Leonardo O Reis, MD, PhD (1)

Results publications

PMID 35599154, PMID 35738969, PMID 37743116